Gemcitabine and carboplatin in combination: An update of phase I and phase II studies in non-small cell lung cancer

Seminars in Oncology

Volumn 26, Issue 1 SUPPL. 4, 1999, Pages 12-18

  Langer, C J ^a   Gandata, D R ^a   Calvert, P ^a   Edelman, M J ^a   Ozols, R F ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; GEMCITABINE;

ADULT; AGED; AREA UNDER THE CURVE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; MAXIMUM PERMISSIBLE DOSE; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA;

EID: 0032893833     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)